| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
SB 202190
|
152121-30-7 |
4-(4-氟苯基)-2-(4-羟基苯基)-5-(4-吡啶基)-1H-咪唑
|
4-(4-氟苯基)-2-(4-羟基苯基)-5-(4-吡啶基)-1H-咪唑;4-[4-(4-氟苯基)-5-(4-吡啶基)-1H-咪唑-2-基]苯酚;4-(4-氟苯基)-2-(4-羟基苯基)-5-(4-吡啶基)-1H-咪唑 25MG;SB-202190;SB 202190
|
C20H14FN3O |
331.34 | |
|
AS 602801 (Bentamapimod)
|
848344-36-5 |
(1,3-苯并噻唑-2-基)[2-[4-[(吗啉-4-基)甲基]苄氧基]嘧啶-4-基]乙腈
|
(1,3-苯并噻唑-2-基)[2-[4-[(吗啉-4-基)甲基]苄氧基]嘧啶-4-基]乙腈;(1,3-苯并噻唑-2-基)[2-[4-[(吗啉-4-基)甲基]苄氧基]嘧啶-4-基]乙腈( AS 602801);AS-602801;BENTAMAPIMOD;AS602801;本塔马莫
|
C25H23N5O2S |
457.54742 | |
|
PD98059
|
167869-21-8 |
2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮
|
2-(2-氨基-3-甲氧苯基)色酮;PD 098,059 (2-(2-氨基-3-甲氧基苯基)-4H-1-苯吡喃-4-酮;2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮,一种非ATP竞争性的MEK抑制剂;2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮
|
C16H13NO3 |
267.28 | |
|
AS703026
|
1236699-92-5 |
N-[(2S)-2,3-二羟基丙基]-3-[(2-氟-4-碘苯基)氨基]-4-吡啶甲酰胺
|
CS-2173;CS-397;PIMASERTIB;MSC1936369B;AS-703026;AS 703026;PIMASERTIB;MSC1936369B;AS-703026;AS 703026;MSC1936369B;PIMASERTIB;N-[(2S)-2,3-二羟基丙基]-3-[(2-氟-4-碘苯基)氨基]-4-吡啶甲酰胺;PIMASERTIB (AS-703026);MSC1936369B;AS703026
|
C15H15FIN3O3 |
431.2007732 | |
|
AZD8330
|
869357-68-6 |
2-(2-氟-4-碘苯氨基)-N-(2-羟基乙氧基)-1,5-二甲基-6-氧代-1,6-二氢吡啶-3-甲酰胺
|
ARRY-424704;ARRY-704;AZD-8330;ARRY424704;ARRY704;AZD 8330;CS-396;2-(2-氟-4-碘苯氨基)-N-(2-羟基乙氧基)-1,5-二甲基-6-氧代-1,6-二氢吡啶-3-甲酰胺;AZD-83302-(2-氟-4-碘苯氨基)-N-(2-羟基乙氧基)-1,6-二氢吡啶-3-甲酰胺;AZD8330;ARRY-424704;ARRY424704;ARRY704;AZD8330
|
C16H17FIN3O4 |
461.23 | 642-441-7 |
|
PD318088
|
391210-00-7 |
5-溴-N-(2,3-二羟基丙氧基)-3,4-二氟-2-[(2-氟-4-碘苯基)氨基]苯甲酰胺
|
5-溴-N-(2,3-二羟基丙氧基)-3,4-二氟-2-[(2-氟-4-碘苯基)氨基]苯甲酰胺
|
C16H13BrF3IN2O4 |
561.0891 | |
|
MEK162 (ARRY-438162)
|
606143-89-9 |
Binimetinib(MEK162)
|
MEK162 5-[(4-溴-2-氟苯基)氨基]-4-氟-N-(2-羟基乙氧基)-1-甲基-1H-苯并咪唑-6-甲酰胺;CS-394;ARRY 162;ARRY 438162;MEK-162;BINIMETINIB;MEK-162;ARRY-162;ARRY-438162;5-[(4-溴-2-氟苯基)氨基]-4-氟-N-(2-羟基乙氧基)-1-甲基-1H-苯并咪唑-6-甲酰胺;BINIMETINIB,ARRY-438162
|
C17H15BrF2N4O3 |
441.226806 | |
|
HA14-1
|
65673-63-4 |
乙基-2-氨基-6-溴-4-(1-氰基-2-乙氧基-2-甲酰)-4H-苯并呋喃-3-羧酸
|
CS-392;乙基-2-氨基-6-溴-4-(1-氰基-2-乙氧基-2-甲酰)-4H-苯并呋喃-3-羧酸;2-氨基-6-溴-ALPHA-氰基-3-(乙氧基羰基)-(ALPHAR,4R)-REL-4H-1-苯并吡喃-4-乙酸乙酯;4H-1-苯并吡喃-4-乙酸,2-氨基-6-溴-Α-氰基-3-(乙氧基羰基)-,乙酯,(ΑR,4R)-REL-;HA14-1;HA-14-1;HA 14-1;2-氨基-6-溴-ALPHA-氰基-3-(乙氧基羰基)-(ALPHAR,4R)-REL-4H-1-苯并吡喃-4-乙酸乙酯 1G
|
C17H17BrN2O5 |
409.23 | |
|
4-[[(4S,5R)-4,5-bis(4-chlorophenyl)-4,5-dihydro-2-[4-methoxy-2-(1-methylethoxy)phenyl]-1H-imidazol-1-yl]carbonyl]-2-Piperazinone
|
675576-98-4 |
4-[[(4S,5R)-4,5-双(4-氯苯基)-4,5-二氢-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-YL]羰基]-2-哌嗪酮
|
CS-391;4-[[(4S,5R)-4,5-双(4-氯苯基)-4,5-二氢-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-YL]羰基]-2-哌嗪酮;4-[[(4S,5-二氢-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮
|
C30H30Cl2N4O4 |
581.497 | |
|
Nutlin-3
|
548472-68-0 |
REL-4-[[(4R,5S)-4,5-双(4-氯苯基)-4,5-二氢-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮
|
NUTLIN3;NUTLIN 3;CS-390;REL-4-[[(4R,5S)-4,5-双(4-氯苯基)-4,5-二氢-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮;4-[4,5-双(4-氯苯基)-2-(4-甲氧基-2-异丙氧基苯基)-4,5-二氢咪唑-1-羰基]哌嗪-2-酮;()-NUTLIN-3
|
C30H30Cl2N4O4 |
581.49 | 200-258-5 |
|
JNJ 26854165
|
881202-45-5 |
N-[2-(1H-吲哚-3-基)乙基]-N'-(4-吡啶基)-1,4-苯二胺
|
CS-389;N-[2-(1H-吲哚-3-基)乙基]-N'-(4-吡啶基)-1,4-苯二胺>98%;JNJ 26854165;JNJ26854165;JNJ-26854165;N-[2-(1H-吲哚-3-基)乙基]-N'-(4-吡啶基)-1,4-苯二胺;N-[2-(1H-吲哚-3-基)乙基]-N'-(4-吡啶基)-1,4-苯二胺(JNJ26854165);HDM2泛素连接酶拮抗剂
|
C21H20N4 |
328.42 | 200-256-5 |
|
VX-765
|
273404-37-8 |
N-(4-氨基-3-氯苯甲酰基)-3-甲基-L-缬氨酰-N-[(2R,3S)-2-乙氧基四氢-5-氧代-3-呋喃基]-L-脯氨酰胺
|
BELNACASAN;VX-765;VX 765;CS-387;VX 765;VX-765;VX765. BELNACASAN;N-(4-氨基-3-氯苯甲酰基)-3-甲基-L-缬氨酰-N-[(2R,3S)-2-乙氧基四氢-5-氧代-3-呋喃基]-L-脯氨酰胺
|
C24H33ClN4O6 |
508.99502 | |
|
AZD1152
|
957881-03-7 |
3-[[7-[3-[乙基[2-(磷酰氧基)乙基]氨基]丙氧基]-4-喹唑啉基]氨基]-N-(3-氟苯基)-1H-吡唑-5-乙酰胺
|
CS-383;3-[[7-[3-[乙基[2-(磷酰氧基)乙基]氨基]丙氧基]-4-喹唑啉基]氨基]-N-(3-氟苯基)-1H-吡唑-5-乙酰胺
|
C26H31FN7O6P |
586.531864 | |
|
NVP-BGT226
|
1245537-68-1 |
1-(3-三氟甲基-4-(哌嗪-1-基)苯基)-8-(6-甲氧基吡啶-3-基)-3-甲基-1H-咪唑并[4,5-C]喹啉-2(3H)-酮马来酸盐
|
BGT-226;NVP BGT226 (BGT226);CS-382;BGT226 (NVP-BGT226);NVP-BGT226;1-(3-三氟甲基-4-(哌嗪-1-基)苯基)-8-(6-甲氧基吡啶-3-基)-3-甲基-1H-咪唑并[4,5-C]喹啉-2(3H(-酮马来酸盐
|
C28H25F3N6O2.C4H4O4 |
650.60447 | |
|
dactolisib
|
915019-65-7 |
2-甲基-2-[4-[3-甲基-2-氧代-8-(喹啉-3-基)-2,3-二氢咪唑并[4,5-C]喹啉-1-基]苯基]丙腈
|
2-甲基-2-(4-(3-甲基-2-氧代-8-(喹啉-3-基)-2,3-二氢-1H-咪唑并[4,5-C]喹啉-1-基)苯基)丙腈;2-甲基-2-[4-[3-甲基-2-氧代-8-(喹啉-3-基)-2,3-二氢咪唑并[4,5-C]喹啉;BEZ235 NVP-BEZ235(BEZ235);苯乙氰,4-[2,3-二氢-3-甲基-2-氧代-8-(3-喹啉基)-1H-咪唑并[4,5-C]喹啉-1-基]-.ALPHA.,.ALPHA.-二甲基-;苯乙氰,5-C]喹啉-1;2-甲基-2-[4-[3-甲基-2-氧代-8-(喹啉-3-基)-2,5-C]喹啉-1-基]苯基]丙腈;CS-381;DACTOLISIB (BEZ235,NVP-BEZ235)
|
C30H23N5O |
469.53652 | 1312995-182-4 |
|
doramapimod
|
285983-48-4 |
1-[2-(4-甲基苯基)-5-叔丁基吡唑-3-基]-3-[4-(2-吗啉-4-基乙氧基)萘-1-基]脲
|
达马莫德;多马莫德;度马莫德;脲,N-[3-(1,1-二甲基乙基)-1-(4-甲基苯基)-1H-吡唑-5-基]-N'-[4-[2-(4-吗啉基)乙氧基]-2-萘基]-
|
C31H37N5O3 |
527.66 | 1308068-626-2 |
|
cediranib
|
288383-20-0 |
西地尼布
|
RECENTIN;AZD2171;AZD 2171;AZD-2171;CS-377;4-(4-氟-2-甲基吲哚-5-基氧基)-6-甲氧基-7-[3-(吡咯烷-1-基)丙氧基]喹唑啉;西地尼布;西地尼布、AZD2172;西地尼布杂质
|
C25H27FN4O3 |
450.51 | 670-946-2 |
|
A 803467
|
944261-79-4 |
5-(4-氯苯基)-N-(3,5-二甲氧基苯基)-2-呋喃甲酰胺
|
5-(4-氯苯基)-N-(3,5-二甲氧基苯基)-2-呋喃甲酰胺;CS-374;5-(4-氯苯基)-N-(3,5-二甲氧基苯基)-2-呋喃甲酰胺>98%;A803467;A 803467
|
C19H16ClNO4 |
357.791 | |
|
4-[2-Amino-6-[(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]-4-pyrimidinyl]-L-phenylalanine ethyl ester N-benzoylglycine salt
|
1137608-69-5 |
4-[2-氨基-6-[(1R)-1-[4-氯-2-(3-甲基-1H-吡唑-1-基)苯基]-2,2,2-三氟乙氧基]-4-嘧啶基]-L-苯丙氨酸乙酯 N-苯甲酰甘氨酸盐
|
LX1606马尿酸盐;CS-373;LX1606 HIPPURATE;TELOTRISTAT ETIPRATE;LX-1606 HIPPURATE;TELOTRISTAT ETIPRATE;LX 1606 HIPPURATE;LX-1606 HIPPURATE;马尿酸盐,LX 1606;4-[2-氨基-6-[(1R)-1-[4-氯-2-(3-甲基-1H-吡唑-1-基)苯基]-2,2,2-三氟乙氧基]-4-嘧啶基]-L-苯丙氨酸乙酯 N-苯甲酰甘氨酸盐;LX 1606 马尿酸盐
|
C36H35ClF3N7O6 |
754.15461 | |
|
LY2940680
|
1258861-20-9 |
4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺
|
LY 2940680;LY2940680;4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺(LY2940680);4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺
|
C26H24F4N6O |
512.51 |
药智官方微信
药智官方微博
